@FiercePharma: Warner Chilcott plots 500 job cuts in European revamp. Item | Follow @FiercePharma
> The National Health Service has sued Reckitt Benckiser for £90 million, following an investigation that ruled the group had abused its dominant position in the UK heartburn market. Report
> Pain treatment developer Nuvo Research has agreed to buy specialty drugmaker ZARS Pharma for about $12.2 million in shares and a possible $14.9 million or more top-up. News
> The FDA has ordered drugmakers to conduct clinical trials involving a total of 53,000 patients to test the safety of long-acting beta-agonists (LABAs), a controversial class of inhaled asthma drugs sold by AstraZeneca, GlaxoSmithKline, Merck and Novartis. Item
> Novartis has sued AstraZeneca's MedImmune unit and a UK-financed research agency in a bid to revoke a patent extension for a drug manufacturing process used to make the active ingredient in its eye drug Lucentis. Article
> AstraZeneca is set to break off its $1.4 billion, seven-year IT outsourcing relationship with IBM, planning to end the relationship in 12-15 months, Computerworld reports. Report
> Ranbaxy Laboratories is expected to play a significant role in parent company Daiichi Sankyo's growth plans in the Chinese generics market, in addition to Japan, as both companies leverage opportunities from their hybrid business model. Story
> Drugmakers should invest in public health campaigns as a way to improve trust in the industry and help with the challenges facing healthcare systems, a new report suggests. News
> The U.S. Supreme Court took no action on a request to speed up a ruling on President Barack Obama's healthcare overhaul law. Report
Biotech News
@FierceBiotech: Regulators hand Eli Lilly another new drug rejection. Item | Follow @FierceBiotech
@JohnCFierce: Domain Associates, GBS Venture Partners and BioPacificVentures hand CoDa Therapeutics a $19M Series B. Story | Follow @JohnCFierce
> Circassia lands $98M venture round as it plots Ph3 trials. Article
> Chatter: Top biotech analyst selects list of likely takeover targets. Story
> Novartis yanks European app for pain drug. Item
> Novartis' Ph3 success advances blockbuster COPD program. Report
Biotech Research News
> Stem cells from schizophrenics show how neurons make fewer connections. Story
> Parents surveyed would want gene tests for kids. News
> Science of addiction could offer alternatives to punishment of addict. Item
> South African center to focus on regional drug-development needs. Report
> Australia sees a gap in cancers represented in clinical trials. Story
> 'Accelerated evolution' gene could help predict preterm births. Article
Manufacturing News
> FDA achievements overlooked by critics. Story
> Manufacturing cost gap closing among U.S., India, China. Article
> Report: Pharma manufacturing "best bet" for college grads. News
> FDA takes another look at cancer drug shortage. Story
> Risk-based manufacturing gains steam at PDA. Report
> Stirling cranks up Canada plant with tablet job. Item
And Finally... Up to 200,000 deaths from malaria could be averted each year if countries switched to a more expensive but more effective drug, Medecins Sans Frontieres said. Report